INR 882.65
(-0.21%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 931.03 Million INR | 62.18% |
2022 | 1.32 Billion INR | 56.14% |
2021 | 846.93 Million INR | 83.64% |
2020 | 461.2 Million INR | 127.04% |
2019 | 203.14 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 577.84 Million INR | -3.2% |
2023 Q2 | 267.64 Million INR | -17.5% |
2023 Q3 | 607.39 Million INR | 126.94% |
2023 Q1 | 324.42 Million INR | -74.45% |
2023 FY | 2.14 Billion INR | 62.18% |
2023 Q4 | 596.94 Million INR | -1.72% |
2022 Q3 | 337.6 Million INR | 0.0% |
2022 FY | 1.32 Billion INR | 56.14% |
2022 Q4 | 1.26 Billion INR | 276.06% |
2021 FY | 846.93 Million INR | 83.64% |
2020 FY | 461.2 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Amrutanjan Health Care Limited | 2.09 Billion INR | 55.539% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -13551.466% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 57.184% |
FDC Limited | 3.49 Billion INR | 73.397% |
Gufic Biosciences Limited | 1.18 Billion INR | 21.537% |
Hikal Limited | 4.46 Billion INR | 79.143% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 56.17% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 57.7% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -125.744% |
Medico Remedies Limited | 59.67 Million INR | -1460.168% |
Nectar Lifesciences Limited | 932.7 Million INR | 0.179% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -1497.292% |
RPG Life Sciences Limited | 1.63 Billion INR | 43.074% |
Sequent Scientific Limited | 2.9 Billion INR | 67.916% |
Shilpa Medicare Limited | 3.33 Billion INR | 72.076% |
Sigachi Industries Limited | 579.88 Million INR | -60.554% |
Themis Medicare Limited | 1.12 Billion INR | 17.3% |
Unichem Laboratories Limited | 6.72 Billion INR | 86.157% |
Venus Remedies Limited | 1.91 Billion INR | 51.415% |
Wanbury Limited | 978.96 Million INR | 4.897% |
ZIM Laboratories Limited | 1.01 Billion INR | 8.097% |
Lupin Limited | 125.09 Billion INR | 99.256% |
Ind-Swift Limited | 946.56 Million INR | 1.641% |
Bajaj HealthCare Limited | 985.34 Million INR | 5.512% |
Aurobindo Pharma Limited | 55.65 Billion INR | 98.327% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 63.548% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 62.36% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -473.902% |
Morepen Laboratories Limited | 1.98 Billion INR | 53.155% |
Laurus Labs Limited | 11.9 Billion INR | 92.183% |
Aarti Drugs Limited | 1.16 Billion INR | 20.253% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 92.002% |
Alembic Limited | 872.45 Million INR | -6.713% |
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 94.133% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 98.017% |
Vaishali Pharma Limited | 84.02 Million INR | -1007.987% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 69.717% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -112.297% |
Jubilant Pharmova Limited | 14.45 Billion INR | 93.559% |
Eris Lifesciences Limited | 4.94 Billion INR | 81.164% |
Windlas Biotech Limited | 1 Billion INR | 7.499% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.396% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 13.327% |
Orchid Pharma Limited | 800.77 Million INR | -16.267% |
Albert David Limited | 1.02 Billion INR | 9.269% |
Hester Biosciences Limited | 908.84 Million INR | -2.442% |
Sakar Healthcare Limited | 204.07 Million INR | -356.211% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 33.63% |
Procter & Gamble Health Limited | 2.99 Billion INR | 68.918% |
Divi's Laboratories Limited | 14.17 Billion INR | 93.43% |
Mankind Pharma Limited | 29.27 Billion INR | 96.819% |
Neuland Laboratories Limited | 2.92 Billion INR | 68.221% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 93.706% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.256% |
Wockhardt Limited | 8.48 Billion INR | 89.021% |
Bal Pharma Limited | 555.62 Million INR | -67.564% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.029% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 34.399% |
Alkem Laboratories Limited | 32.83 Billion INR | 97.165% |
Valiant Laboratories Limited | 138.02 Million INR | -574.518% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.944% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | -104.359% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -6450.552% |
Granules India Limited | 10.31 Billion INR | 90.972% |
Medicamen Biotech Limited | 335.16 Million INR | -177.781% |
Ipca Laboratories Limited | 18.98 Billion INR | 95.097% |
Brooks Laboratories Limited | 51.18 Million INR | -1719.129% |
Syncom Formulations (India) Limited | 345.63 Million INR | -169.37% |
Piramal Enterprises Limited | 63.65 Billion INR | 98.537% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.654% |
NATCO Pharma Limited | 10.05 Billion INR | 90.743% |
Suven Life Sciences Limited | 109.75 Million INR | -748.319% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -1917.138% |
Strides Pharma Science Limited | 9.16 Billion INR | 89.838% |
Indoco Remedies Limited | 12.06 Billion INR | 92.281% |
Alpa Laboratories Limited | 127.38 Million INR | -630.908% |
Lasa Supergenerics Limited | 291.17 Million INR | -219.75% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 69.74% |